Goei Dustin, Flu Willem-Jan, Hoeks Sanne E, Galal Wael, Dunkelgrun Martin, Boersma Eric, Kuijper Ruud, van Kuijk Jan-Peter, Winkel Tamara A, Schouten Olaf, Bax Jeroen J, Poldermans Don
Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.
N-terminal pro-B-type natriuretic peptide (NT-proBNP) predicts adverse cardiac outcome in patients undergoing vascular surgery. However, several conditions might influence this prognostic value, including anemia. In this study, we evaluated whether anemia confounds the prognostic value of NT-proBNP for predicting cardiac events in patients undergoing vascular surgery.
A detailed cardiac history, resting echocardiography, and hemoglobin and NT-proBNP levels were obtained in 666 patients before vascular surgery. Anemia was defined as serum hemoglobin <13 g/dL for men and <12 g/dL for women. Troponin T measurements and 12-lead electrocardiograms were performed on postoperative days 1, 3, 7, and 30 and whenever clinically indicated. The primary end point of the study was the composite of 30-day postoperative cardiovascular death, nonfatal myocardial infarction, and troponin T release. Receiver operating characteristic curve analysis was used to assess the optimal cutoff value of NT-proBNP for the prediction of the composite end point. Multivariable regression analysis was used to assess the additional value of NT-proBNP for the prediction of postoperative cardiac events in nonanemic and anemic patients.
Anemia was present in 206 patients (31%) before surgery. Hemoglobin level was inversely related with the NT-proBNP levels (beta coefficient = -2.242; P = 0.025). The optimal predictive cutoff value of NT-proBNP for predicting the composite cardiovascular outcome was 350 pg/mL. After adjustment for clinical cardiac risk factors, both anemia (odds ratio [OR] 1.53; 95% confidence interval [CI]: 1.07-2.99) and increased levels of NT-proBNP (OR 4.09; 95% CI: 2.19-7.64) remained independent predictors for postoperative cardiac events. However, increased levels of NT-proBNP were not predictive for the risk of adverse cardiac events in the subgroup of anemic patients (OR 2.16; 95% CI: 0.90-5.21).
Both anemia and NT-proBNP are independently associated with an increased risk for postoperative cardiac events in patients undergoing vascular surgery. NT-proBNP has less predictive value in anemic patients.
N末端B型利钠肽原(NT-proBNP)可预测血管手术患者的不良心脏结局。然而,包括贫血在内的几种情况可能会影响这种预后价值。在本研究中,我们评估了贫血是否会混淆NT-proBNP对血管手术患者心脏事件的预后预测价值。
在666例患者进行血管手术前,获取详细的心脏病史、静息超声心动图、血红蛋白和NT-proBNP水平。贫血定义为男性血清血红蛋白<13 g/dL,女性血清血红蛋白<12 g/dL。在术后第1、3、7和30天以及临床指征需要时进行肌钙蛋白T测量和12导联心电图检查。本研究的主要终点是术后30天心血管死亡、非致命性心肌梗死和肌钙蛋白T释放的复合终点。采用受试者工作特征曲线分析评估NT-proBNP预测复合终点的最佳临界值。多变量回归分析用于评估NT-proBNP在非贫血和贫血患者中预测术后心脏事件的附加价值。
术前206例患者(31%)存在贫血。血红蛋白水平与NT-proBNP水平呈负相关(β系数=-2.242;P=0.025)。NT-proBNP预测复合心血管结局的最佳临界值为350 pg/mL。在调整临床心脏危险因素后,贫血(比值比[OR]1.53;95%置信区间[CI]:1.07-2.99)和NT-proBNP水平升高(OR 4.09;95% CI:2.19-7.64)仍然是术后心脏事件的独立预测因素。然而,NT-proBNP水平升高在贫血患者亚组中并不能预测不良心脏事件的风险(OR 2.16;95% CI:0.90-5.21)。
贫血和NT-proBNP均与血管手术患者术后心脏事件风险增加独立相关。NT-proBNP在贫血患者中的预测价值较低。